Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gastric Cancer

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 110 articles:
HTML format
Text format



Single Articles


    April 2017
  1. TAHARA T, Tahara S, Horiguchi N, Kawamura T, et al
    Telomere Length in Leukocyte DNA in Gastric Cancer Patients and its Association with Clinicopathological Features and Prognosis.
    Anticancer Res. 2017;37:1997-2001.
    PubMed     Text format     Abstract available


  2. KUNIZAKI M, Fukuda A, Wakata K, Tominaga T, et al
    Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
    Anticancer Res. 2017;37:1979-1984.
    PubMed     Text format     Abstract available


    March 2017
  3. FUKUCHI M, Mochiki E, Ishiguro T, Ogura T, et al
    Efficacy of Conversion Surgery Following S-1 plus Cisplatin or Oxaliplatin Chemotherapy for Unresectable Gastric Cancer.
    Anticancer Res. 2017;37:1343-1347.
    PubMed     Text format     Abstract available


  4. MITA K, Ito H, Ota E, Takahashi K, et al
    Adjuvant Chemotherapy with S-1 plus Cisplatin for Patients with Stage III Gastric Cancer After Curative Resection.
    Anticancer Res. 2017;37:1329-1333.
    PubMed     Text format     Abstract available


  5. AHN SY, Kim J, Kim MA, Choi J, et al
    Increased HGF Expression Induces Resistance to c-MET Tyrosine Kinase Inhibitors in Gastric Cancer.
    Anticancer Res. 2017;37:1127-1138.
    PubMed     Text format     Abstract available


  6. DAI X, Liu D, Liu M, Zhang X, et al
    Anti-metastatic Efficacy of Traditional Chinese Medicine (TCM) Ginsenoside Conjugated to a VEFGR-3 Antibody on Human Gastric Cancer in an Orthotopic Mouse Model.
    Anticancer Res. 2017;37:979-986.
    PubMed     Text format     Abstract available


    February 2017
  7. SATOH T, Kaira K, Takahashi K, Takahashi N, et al
    Prognostic Significance of the Expression of CD98 (4F2hc) in Gastric Cancer.
    Anticancer Res. 2017;37:631-636.
    PubMed     Text format     Abstract available


  8. BAUER G
    Central Signaling Elements of Intercellular Reactive Oxygen/Nitrogen Species-dependent Induction of Apoptosis in Malignant Cells.
    Anticancer Res. 2017;37:499-513.
    PubMed     Text format     Abstract available


  9. BACKMAN S, Norlen O, Eriksson B, Skogseid B, et al
    Detection of Somatic Mutations in Gastroenteropancreatic Neuroendocrine Tumors Using Targeted Deep Sequencing.
    Anticancer Res. 2017;37:705-712.
    PubMed     Text format     Abstract available


  10. PROUET P, Giri S, Wiedower E, Fintel A, et al
    Addition of Rituximab to Chemotherapy Reduced the Rate of Surgery for Gastric-DLBCL Without Increasing Early Mortality.
    Anticancer Res. 2017;37:813-817.
    PubMed     Text format     Abstract available


    January 2017
  11. OGATA K, Yanai M, Kuriyama K, Suzuki M, et al
    Double Endoscopic Intraluminal Operation (DEILO) for Early Gastric Cancer: Outcome of Novel Procedure for Endoscopic Submucosal Dissection.
    Anticancer Res. 2017;37:343-347.
    PubMed     Text format     Abstract available


  12. SUGIYAMA K, Narita Y, Kadowaki S, Ura T, et al
    Platinum-based Doublet Chemotherapy for Advanced Gastric Cancer with Disseminated Intravascular Coagulation.
    Anticancer Res. 2017;37:309-313.
    PubMed     Text format     Abstract available


  13. JUKIC Z, Radulovic P, Stojkovic R, Mijic A, et al
    Gender Difference in Distribution of Estrogen and Androgen Receptors in Intestinal-type Gastric Cancer.
    Anticancer Res. 2017;37:197-202.
    PubMed     Text format     Abstract available


  14. KOGURE N, Yokobori T, Ogata K, Altan B, et al
    Low Expression of FBXO45 Is Associated with Gastric Cancer Progression and Poor Prognosis.
    Anticancer Res. 2017;37:191-196.
    PubMed     Text format     Abstract available


  15. LEE D, Yu EJ, Ham IH, Hur H, et al
    Clinicopathological Implication of Insulin-like Growth Factor-II mRNA-Binding Protein 3 (IMP3) Expression in Gastric Cancer.
    Anticancer Res. 2017;37:135-142.
    PubMed     Text format     Abstract available


    December 2016
  16. FUKUCHI M, Mochiki E, Ishiguro T, Ogura T, et al
    Efficacy of Nab-Paclitaxel as Second-line Chemotherapy for Unresectable or Recurrent Gastric Cancer.
    Anticancer Res. 2016;36:6699-6703.
    PubMed     Text format     Abstract available


  17. TOIYAMA Y, Shimura T, Yasuda H, Fujikawa H, et al
    Clinical Burden of C-Reactive Protein/Albumin Ratio Before Curative Surgery for Patients with Gastric Cancer.
    Anticancer Res. 2016;36:6491-6498.
    PubMed     Text format     Abstract available


    November 2016
  18. ZHENG LC, Yang MD, Kuo CL, Lin CH, et al
    Norcantharidin-induced Apoptosis of AGS Human Gastric Cancer Cells Through Reactive Oxygen Species Production, and Caspase- and Mitochondria-dependent Signaling Pathways.
    Anticancer Res. 2016;36:6031-6042.
    PubMed     Text format     Abstract available


  19. HAYASHI N, Kataoka H, Yano S, Kikuchi JI, et al
    Anticancer Effects of a New Aminosugar-conjugated Platinum Complex Agent Against Cisplatin-resistant Gastric Cancer.
    Anticancer Res. 2016;36:6005-6009.
    PubMed     Text format     Abstract available


    October 2016
  20. ARIGAMI T, Uenosono Y, Ishigami S, Yanagita S, et al
    Clinical Impact of Stomach-partitioning Gastrojejunostomy with Braun Enteroenterostomy for Patients with Gastric Outlet Obstruction Caused by Unresectable Gastric Cancer.
    Anticancer Res. 2016;36:5431-5436.
    PubMed     Text format     Abstract available


  21. ALTAN B, Yokobori T, Ide M, Bai T, et al
    High Expression of MRE11-RAD50-NBS1 Is Associated with Poor Prognosis and Chemoresistance in Gastric Cancer.
    Anticancer Res. 2016;36:5237-5247.
    PubMed     Text format     Abstract available


  22. YAWATA K, Osada S, Tanahashi T, Matsui S, et al
    The Significant Role of Cyclin D1 in the Synergistic Growth-inhibitory Effect of Combined Therapy of Vandetanib with 5-Fluorouracil for Gastric Cancer.
    Anticancer Res. 2016;36:5215-5226.
    PubMed     Text format     Abstract available


  23. LEMOINE N, Adenis A, Bouche O, Duhamel A, et al
    Signet Ring Cells and Efficacy of First-line Chemotherapy in Advanced Gastric or Oesogastric Junction Adenocarcinoma.
    Anticancer Res. 2016;36:5543-5549.
    PubMed     Text format     Abstract available


  24. KNIEF J, Reddemann K, Petrova E, Herhahn T, et al
    High Density of Tumor-infiltrating B-Lymphocytes and Plasma Cells Signifies Prolonged Overall Survival in Adenocarcinoma of the Esophagogastric Junction.
    Anticancer Res. 2016;36:5339-5345.
    PubMed     Text format     Abstract available


    September 2016
  25. KIM EY, Jun KH, Jung JH, Jo YS, et al
    Laparoscopic Gastrectomy Followed by Chemotherapy for Advanced Gastric Cancer Diagnosed During Pregnancy: A Case Report.
    Anticancer Res. 2016;36:4813-6.
    PubMed     Text format     Abstract available


  26. KIM DJ, Kim W
    Laparoscopy-assisted Proximal Gastrectomy with Double Tract Anastomosis Is Beneficial for Vitamin B12 and Iron Absorption.
    Anticancer Res. 2016;36:4753-8.
    PubMed     Text format     Abstract available


    August 2016
  27. FUKUCHI M, Mochiki E, Ishiguro T, Ogura T, et al
    Improved Efficacy by Addition of Protein-bound Polysaccharide K to Adjuvant Chemotherapy for Advanced Gastric Cancer.
    Anticancer Res. 2016;36:4237-41.
    PubMed     Text format     Abstract available


  28. CHOU NH, Tsai CY, Tu YT, Wang KC, et al
    Isocitrate Dehydrogenase 2 Dysfunction Contributes to 5-hydroxymethylcytosine Depletion in Gastric Cancer Cells.
    Anticancer Res. 2016;36:3983-90.
    PubMed     Text format     Abstract available


  29. ROMAN LD, Lukyanchuk R, Sablin OA, Araslanova EI, et al
    Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel(R)) in St. Petersburg.
    Anticancer Res. 2016;36:4129-38.
    PubMed     Text format     Abstract available


    June 2016
  30. KOMATSU S, Ichikawa D, Kosuga T, Okamoto K, et al
    Clinical Impact of Laparoscopy and Endoscopy Cooperative Surgery (LECS) on Gastric Submucosal Tumor After its Standardization.
    Anticancer Res. 2016;36:3041-7.
    PubMed     Text format     Abstract available


  31. YONENAGA Y, Kurosawa M, Mise M, Yamagishi M, et al
    Pancreatic-type Acinar Cell Carcinoma of the Stomach Included in Multiple Primary Carcinomas.
    Anticancer Res. 2016;36:2855-64.
    PubMed     Text format     Abstract available


    May 2016
  32. FUKUCHI M, Mochiki E, Ishiguro T, Ogura T, et al
    Prognostic Factors for Gastric Cancer with Cancer Cells in the Peritoneal Cavity.
    Anticancer Res. 2016;36:2481-5.
    PubMed     Text format     Abstract available


  33. MURAKAMI T, Zhang Y, Wang X, Hiroshima Y, et al
    Orthotopic Implantation of Intact Tumor Tissue Leads to Metastasis of OCUM-2MD3 Human Gastric Cancer in Nude Mice Visualized in Real Time by Intravital Fluorescence Imaging.
    Anticancer Res. 2016;36:2125-30.
    PubMed     Text format     Abstract available


    April 2016
  34. KIM EY, Choi HJ, Cho JB, Lee J, et al
    Totally Laparoscopic Total Gastrectomy Versus Laparoscopically Assisted Total Gastrectomy for Gastric Cancer.
    Anticancer Res. 2016;36:1999-2003.
    PubMed     Text format     Abstract available


  35. KUCERA R, Smid D, Topolcan O, Karlikova M, et al
    Searching for New Biomarkers and the Use of Multivariate Analysis in Gastric Cancer Diagnostics.
    Anticancer Res. 2016;36:1967-71.
    PubMed     Text format     Abstract available


  36. KAWAGUCHI T, Komatsu S, Ichikawa D, Kimura YU, et al
    Prognostic Influence of the Extent of Lymph Node Dissection and Perioperative Comorbidities in Patients with Gastric Cancer.
    Anticancer Res. 2016;36:1917-22.
    PubMed     Text format     Abstract available


  37. OHASHI T, Komatsu S, Ichikawa D, Kosuga T, et al
    Tumor Index as a Combined Indicator of Tumor Depth and Size in Gastric Cancer.
    Anticancer Res. 2016;36:1895-900.
    PubMed     Text format     Abstract available


  38. NAKASHIMA Y, Nakanishi R, Sugiyama M, Ohgaki K, et al
    Laparoscopic Resection of Gastric Cancer in a Patient with Chronic Lymphocytic Leukemia Accompanied by Neutropenia.
    Anticancer Res. 2016;36:1779-83.
    PubMed     Text format     Abstract available


  39. KOSAKA T, Akiyama H, Makino H, Kimura J, et al
    Impact of Neoadjuvant Chemotherapy Among Patients with Pancreatic Fistula After Gastrectomy for Advanced Gastric Cancer.
    Anticancer Res. 2016;36:1773-7.
    PubMed     Text format     Abstract available


  40. MAKATSORIS T, Tsamandas AC, Strimpakos A, Alexopoulou Z, et al
    HER Family Protein Expression in a Greek Population with Gastric Cancer. A Retrospective Hellenic Cooperative Oncology Group Study.
    Anticancer Res. 2016;36:1581-90.
    PubMed     Text format     Abstract available


  41. TANAKAYA K, Yamaguchi T, Ishikawa H, Hinoi T, et al
    Causes of Cancer Death Among First-Degree Relatives in Japanese Families with Lynch Syndrome.
    Anticancer Res. 2016;36:1985-9.
    PubMed     Text format     Abstract available


    March 2016
  42. SHAO S, Sun PH, Satherley LK, Gao X, et al
    Reduced RanBPM Expression Is Associated with Distant Metastasis in Gastric Cancer and Chemoresistance.
    Anticancer Res. 2016;36:1295-303.
    PubMed     Text format     Abstract available


  43. JIA S, Cai J
    Update on Biomarkers in Development of Anti-angiogenic Drugs in Gastric Cancer.
    Anticancer Res. 2016;36:1111-8.
    PubMed     Text format     Abstract available


  44. SUN J, Ling B, Xu X, Ma R, et al
    Decreased Expression of Tumor-suppressor Gene LKB1 Correlates with Poor Prognosis in Human Gastric Cancer.
    Anticancer Res. 2016;36:869-75.
    PubMed     Text format     Abstract available


  45. ZIMMERMANN N, Lazar-Karsten P, Keck T, Billmann F, et al
    Expression Pattern of CDX2, Estrogen and Progesterone Receptors in Primary Gastroenteropancreatic Neuroendocrine Tumors and Metastases.
    Anticancer Res. 2016;36:921-4.
    PubMed     Text format     Abstract available


    February 2016
  46. KUBO H, Komatsu S, Ichikawa D, Kawaguchi T, et al
    Impact of Body Weight Loss on Recurrence After Curative Gastrectomy for Gastric Cancer.
    Anticancer Res. 2016;36:807-13.
    PubMed     Text format     Abstract available


    January 2016
  47. KURILOVICH S, Belkovets A, Reshetnikov O, Openko T, et al
    Stomach-specific Biomarkers (GastroPanel) Can Predict the Development of Gastric Cancer in a Caucasian Population: A Longitudinal Nested Case-Control Study in Siberia.
    Anticancer Res. 2016;36:247-53.
    PubMed     Text format     Abstract available


  48. MIN HL, Kim J, Kim WH, Jang BG, et al
    Epigenetic Silencing of the Putative Tumor Suppressor Gene GLDC (Glycine Dehydrogenase) in Gastric Carcinoma.
    Anticancer Res. 2016;36:179-87.
    PubMed     Text format     Abstract available


  49. MASUDA GO, Yashiro M, Kitayama K, Miki Y, et al
    Clinicopathological Correlations of Autophagy-related Proteins LC3, Beclin 1 and p62 in Gastric Cancer.
    Anticancer Res. 2016;36:129-36.
    PubMed     Text format     Abstract available


    December 2015
  50. MATSUMOTO T, Matsuda D, Honma K, Aoyagi Y, et al
    One-stage Procedure for Concomitant Abdominal Aortic Aneurysm and Gastric Cancer.
    Anticancer Res. 2015;35:6909-12.
    PubMed     Text format     Abstract available


  51. ASO T, Uozaki H, Morita S, Kumagai A, et al
    Loss of ARID1A, ARID1B, and ARID2 Expression During Progression of Gastric Cancer.
    Anticancer Res. 2015;35:6819-27.
    PubMed     Text format     Abstract available


  52. FUJIWARA Y, Omori T, Demura K, Miyata H, et al
    A Multidisciplinary Approach for Advanced Gastric Cancer with Paraaortic Lymph Node Metastasis.
    Anticancer Res. 2015;35:6739-45.
    PubMed     Text format     Abstract available


  53. SCHMIDT K, Moser C, Hellerbrand C, Zieker D, et al
    Targeting Fibroblast Growth Factor Receptor (FGFR) with BGJ398 in a Gastric Cancer Model.
    Anticancer Res. 2015;35:6655-65.
    PubMed     Text format     Abstract available


  54. OHYAMA M, Tsuchiya A, Kaku Y, Kanno T, et al
    Phosphatidylinositol Derivatives Induce Gastric Cancer Cell Apoptosis by Accumulating AIF and AMID in the Nucleus.
    Anticancer Res. 2015;35:6563-71.
    PubMed     Text format     Abstract available


    November 2015
  55. FUKUCHI M, Ishiguro T, Ogata K, Kimura A, et al
    Risk Factors for Recurrence After Curative Conversion Surgery for Unresectable Gastric Cancer.
    Anticancer Res. 2015;35:6183-7.
    PubMed     Text format     Abstract available


  56. HEINZELMANN S, Bauer G
    Site-specific Effects of DUOX1-Related Peroxidase on Intercellular Apoptosis Signaling.
    Anticancer Res. 2015;35:5955-71.
    PubMed     Text format     Abstract available


  57. POTTGIESSER SJ, Heinzelmann S, Bauer G
    Intercellular HOCl-mediated Apoptosis Induction in Malignant Cells: Interplay Between NOX1-Dependent Superoxide Anion Generation and DUOX-related HOCl-generating Peroxidase Activity.
    Anticancer Res. 2015;35:5927-43.
    PubMed     Text format     Abstract available


    October 2015

  58. Laparoscopic Gastrectomy for Gastric Cancer.
    Anticancer Res. 2015;35:5709.
    PubMed     Text format    


  59. TAMURA T, Ohira M, Tanaka H, Muguruma K, et al
    Programmed Death-1 Ligand-1 (PDL1) Expression Is Associated with the Prognosis of Patients with Stage II/III Gastric Cancer.
    Anticancer Res. 2015;35:5369-76.
    PubMed     Text format     Abstract available


  60. KOSAKA T, Davydova J, Ono HA, Akiyama H, et al
    Imaging and Antitumoral Effect of a Cyclo-oxygenase 2-specific Replicative Adenovirus for Small Metastatic Gastric Cancer Lesions.
    Anticancer Res. 2015;35:5201-10.
    PubMed     Text format     Abstract available


    September 2015
  61. SHOJI H, Yamada Y, Okita N, Takashima A, et al
    Amplification of FGFR2 Gene in Patients with Advanced Gastric Cancer Receiving Chemotherapy: Prevalence and Prognostic Significance.
    Anticancer Res. 2015;35:5055-61.
    PubMed     Text format     Abstract available


  62. JI HX, Chang WS, Tsai CW, Wang JY, et al
    Contribution of DNA Repair Xeroderma Pigmentosum Group D Genotype to Gastric Cancer Risk in Taiwan.
    Anticancer Res. 2015;35:4975-4981.
    PubMed     Text format     Abstract available


  63. YAMAMOTO M, Kawano H, Yamaguchi S, Egashira A, et al
    Comparison of Neoadjuvant Chemotherapy to Surgery Followed by Adjuvant Chemotherapy in Japanese Patients with Peritoneal Lavage Cytology Positive for Gastric Carcinoma.
    Anticancer Res. 2015;35:4859-63.
    PubMed     Text format     Abstract available


  64. SHIMURA T, Toiyama Y, Tanaka K, Saigusa S, et al
    Angiopoietin-like Protein 2 as a Predictor of Early Recurrence in Patients After Curative Surgery for Gastric Cancer.
    Anticancer Res. 2015;35:4633-9.
    PubMed     Text format     Abstract available


  65. NUKATSUKA M, Nakagawa F, Takechi T
    Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
    Anticancer Res. 2015;35:4605-15.
    PubMed     Text format     Abstract available


  66. CHROM P, Stec R, Szczylik C
    Second-line Treatment of Advanced Gastric Cancer: Current Options and Future Perspectives.
    Anticancer Res. 2015;35:4575-83.
    PubMed     Text format     Abstract available


    July 2015
  67. TOYOKAWA T, Ohira M, Sakurai K, Kubo N, et al
    The Role of Adjuvant Chemotherapy for Patients with Stage IB Gastric Cancer.
    Anticancer Res. 2015;35:4091-7.
    PubMed     Text format     Abstract available


  68. KIM SH, Lee OJ, Kwon JL, Kim JM, et al
    Altered Expression of Yes-associated Protein and beta-Catenin in Non-neoplastic and Neoplastic Gastric Surface Epithelia.
    Anticancer Res. 2015;35:3925-31.
    PubMed     Text format     Abstract available


  69. JERNMAN J, Hagstrom J, Maenpaa H, Valimaki MJ, et al
    Expression of Stem Cell-associated Marker HES77 in Rectal Neuroendocrine Tumors.
    Anticancer Res. 2015;35:3767-72.
    PubMed     Text format     Abstract available


    June 2015
  70. SHIDA A, Futawatari N, Fukuyama T, Ichiki Y, et al
    Frequent High Expression of Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1) in Gastric Cancer.
    Anticancer Res. 2015;35:3575-9.
    PubMed     Text format     Abstract available


  71. KIM JY, Ryoo HM, Bae SH, Kang BW, et al
    Multi-center Randomized Phase II Study of Weekly Docetaxel Versus Weekly Docetaxel-plus-Oxaliplatin as a Second-line Chemotherapy for Patients with Advanced Gastric Cancer.
    Anticancer Res. 2015;35:3531-6.
    PubMed     Text format     Abstract available


  72. OHI M, Mori K, Toiyama Y, Mohri Y, et al
    Preoperative prediction of peritoneal metastasis in gastric cancer as an indicator for neoadjuvant treatment.
    Anticancer Res. 2015;35:3511-8.
    PubMed     Text format     Abstract available


  73. KIM HS, Lee HS, Nam KH, Choi J, et al
    Telomere length abnormalities and telomerase RNA component expression in gastroenteropancreatic neuroendocrine tumors.
    Anticancer Res. 2015;35:3501-10.
    PubMed     Text format     Abstract available


    May 2015
  74. KATSUBE T, Murayama M, Yamaguchi K, Usuda A, et al
    Additional Surgery After Non-curative Resection of ESD for Early Gastric Cancer.
    Anticancer Res. 2015;35:2969-74.
    PubMed     Text format     Abstract available


  75. CACINA C, Arikan S, Duzkoylu Y, Dogan MB, et al
    Analyses of EGF A61G Gene Variation and Serum EGF Level on Gastric Cancer Susceptibility and Clinicopathological Parameters.
    Anticancer Res. 2015;35:2709-13.
    PubMed     Text format     Abstract available


  76. CHOI B, Lee EJ, Park YS, Kim SM, et al
    Pentraxin-3 Silencing Suppresses Gastric Cancer-related Inflammation by Inhibiting Chemotactic Migration of Macrophages.
    Anticancer Res. 2015;35:2663-8.
    PubMed     Text format     Abstract available


    April 2015
  77. OTSU H, Oki E, Ikawa-Yoshida A, Kawano H, et al
    Correlation of HER2 Expression with Clinicopathological Characteristics and Prognosis in Resectable Gastric Cancer.
    Anticancer Res. 2015;35:2441-6.
    PubMed     Text format     Abstract available


  78. ISHIGAMI S, Arigami T, Okumura H, Uchikado Y, et al
    Human Leukocyte Antigen (HLA)-E and HLA-F Expression in Gastric Cancer.
    Anticancer Res. 2015;35:2279-85.
    PubMed     Text format     Abstract available


  79. LIU YY, Tsai CY, Yeh CN, Chiang KC, et al
    Gastric Cancer Patients with End-stage Renal Disease Who Underwent Radical Gastrectomy.
    Anticancer Res. 2015;35:2263-8.
    PubMed     Text format     Abstract available


  80. KUROKAWA Y, Hamakawa T, Miyazaki Y, Takahashi T, et al
    Preoperative systemic and intraperitoneal chemotherapy consisting of s-1, Cisplatin and docetaxel in patients with marginally resectable gastric cancer.
    Anticancer Res. 2015;35:2223-8.
    PubMed     Text format     Abstract available


  81. KOSUGA T, Ichikawa D, Okamoto K, Komatsu S, et al
    Impact of Age on Early Surgical Outcomes of Laparoscopy-assisted Gastrectomy with Suprapancreatic Nodal Dissection for Clinical Stage I Gastric Cancer.
    Anticancer Res. 2015;35:2191-8.
    PubMed     Text format     Abstract available


  82. ETO S, Yoshikawa K, Shimada M, Higashijima J, et al
    The Relationship of CD133, Histone Deacetylase 1 and Thrombospondin-1 in Gastric Cancer.
    Anticancer Res. 2015;35:2071-6.
    PubMed     Text format     Abstract available


  83. VIEIRA PC, Burbano RM, Fernandes DC, Montenegro RC, et al
    Population stratification effect on cancer susceptibility in an admixed population from Brazilian Amazon.
    Anticancer Res. 2015;35:2009-14.
    PubMed     Text format     Abstract available


    March 2015
  84. NUKATSUKA M, Nakagawa F, Saito H, Sakata M, et al
    Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Irinotecan Hydrochloride on Human Colorectal and Gastric Cancer Xenografts.
    Anticancer Res. 2015;35:1437-45.
    PubMed     Text format     Abstract available


  85. KUO WT, Ho MR, Wu CW, Fang WL, et al
    Interrogation of MicroRNAs Involved in Gastric Cancer Using 5p-Arm and 3p-Arm Annotated MicroRNAs.
    Anticancer Res. 2015;35:1345-52.
    PubMed     Text format     Abstract available


  86. HOSHINO I, Maruyama T, Fujito H, Tamura Y, et al
    Detection of Peritoneal Dissemination with Near-infrared Fluorescence Laparoscopic Imaging Using a Liposomal Formulation of a Synthesized Indocyanine Green Liposomal Derivative.
    Anticancer Res. 2015;35:1353-9.
    PubMed     Text format     Abstract available


    February 2015
  87. YAMASHITA K, Hosoda K, Katada N, Moriya H, et al
    Survival Outcome of Borrmann Type IV Gastric Cancer Potentially Improved by Multimodality Treatment.
    Anticancer Res. 2015;35:897-906.
    PubMed     Text format     Abstract available


    January 2015
  88. NAKANOKO T, Kakeji Y, Ando K, Nakashima Y, et al
    Assessment of surgical treatment and postoperative nutrition in gastric cancer patients older than 80 years.
    Anticancer Res. 2015;35:511-5.
    PubMed     Text format     Abstract available


  89. IENI A, Branca G, Parisi A, Fedele F, et al
    Neutrophil-rich Gastric Carcinoma in the Integrated Cancer Registry of Eastern Sicily, Italy.
    Anticancer Res. 2015;35:487-92.
    PubMed     Text format     Abstract available


  90. TAKAHASHI T, Saikawa Y, Fukuda K, Nakamura R, et al
    Phase I Study of S-1 plus Fractional Cisplatin as Adjuvant Chemotherapy for Advanced Gastric Cancer in an Outpatient Setting (KOGC-03).
    Anticancer Res. 2015;35:467-71.
    PubMed     Text format     Abstract available


  91. ITO S, Oki E, Nakashima Y, Ando K, et al
    Clinical Significance of Adjuvant Surgery Following Chemotherapy for Patients with Initially Unresectable Stage IV Gastric Cancer.
    Anticancer Res. 2015;35:401-6.
    PubMed     Text format     Abstract available


  92. TOYOKAWA T, Tanaka H, Muguruma K, Tamura T, et al
    Primary gastric small cell carcinoma: a series of seven cases.
    Anticancer Res. 2015;35:563-7.
    PubMed     Text format     Abstract available


  93. FUKUCHI M, Mochiki E, Suzuki O, Ishiguro T, et al
    Factors predicting recurrence in patients with Siewert type II carcinoma treated with curative resection.
    Anticancer Res. 2015;35:505-9.
    PubMed     Text format     Abstract available


  94. HOSODA K, Yamashita K, Katada N, Moriya H, et al
    Impact of lower mediastinal lymphadenectomy for the treatment of esophagogastric junction carcinoma.
    Anticancer Res. 2015;35:445-56.
    PubMed     Text format     Abstract available


  95. HOSODA K, Yamashita K, Katada N, Moriya H, et al
    Benefit of neoadjuvant chemotherapy for Siewert type II esophagogastric junction adenocarcinoma.
    Anticancer Res. 2015;35:419-25.
    PubMed     Text format     Abstract available


    December 2014
  96. NAMIKAWA T, Munekage E, Maeda H, Kitagawa H, et al
    Feasibility study of supportive care using lafutidine, a histamine h2 receptor antagonist, to prevent gastrointestinal toxicity during chemotherapy for gastric cancer.
    Anticancer Res. 2014;34:7297-301.
    PubMed     Text format     Abstract available


  97. ISHIZUKA M, Oyama Y, Abe A, Tago K, et al
    Clinical Significance of an Inflammation-based Prognostic System for Gastric Cancer Patients with a Preoperative Normal Serum Level of Carcinoembryonic Antigen.
    Anticancer Res. 2014;34:7219-26.
    PubMed     Text format     Abstract available


  98. KUPCINSKAS J, Wex T, Link A, Bartuseviciute R, et al
    PSCA and MUC1 Gene Polymorphisms Are Linked with Gastric Cancer and Pre-malignant Gastric Conditions.
    Anticancer Res. 2014;34:7167-75.
    PubMed     Text format     Abstract available


  99. TOKUMOTO M, Tanaka H, Ohira M, Go Y, et al
    A positive correlation between neutrophils in regional lymph nodes and progression of gastric cancer.
    Anticancer Res. 2014;34:7129-36.
    PubMed     Text format     Abstract available


  100. SU CC
    Tanshinone IIA Inhibits Gastric Carcinoma AGS Cells Through Increasing p-p38, p-JNK and p53 but Reducing p-ERK, CDC2 and Cyclin B1 Expression.
    Anticancer Res. 2014;34:7097-110.
    PubMed     Text format     Abstract available


  101. CINAR P, Calkins SM, Venook AP, Kelley RK, et al
    A case series of patients with HER2-overexpressed primary metastatic gastroesophageal adenocarcinoma.
    Anticancer Res. 2014;34:7357-60.
    PubMed     Text format     Abstract available


  102. HIYOSHI Y, Oki E, Ando K, Ito S, et al
    Outcome of esophagojejunostomy during totally laparoscopic total gastrectomy: a single-center retrospective study.
    Anticancer Res. 2014;34:7227-32.
    PubMed     Text format     Abstract available


    November 2014
  103. LEE SJ, Sohn TS, Lee J, Park SH, et al
    Adjuvant Chemoradiation with 5-Fluorouracil/Leucovorin versus S-1 in Gastric Cancer Patients Following D2 Lymph Node Dissection Surgery: A Feasibility Study.
    Anticancer Res. 2014;34:6585-6591.
    PubMed     Text format     Abstract available


  104. MASUDA T, Nakashima Y, Ando K, Yoshinaga K, et al
    Nuclear expression of chemokine receptor CXCR4 indicates poorer prognosis in gastric cancer.
    Anticancer Res. 2014;34:6397-403.
    PubMed     Text format     Abstract available


  105. AURELLO P, Magistri P, Nigri G, Petrucciani N, et al
    Surgical Management of Microscopic Positive Resection Margin After Gastrectomy for Gastric Cancer: A Systematic Review of Gastric R1 Management.
    Anticancer Res. 2014;34:6283-6288.
    PubMed     Text format     Abstract available


  106. SEABRA AD, Araujo TM, Mello Junior FA, Di Felipe Avila Alcantara D, et al
    High-density array comparative genomic hybridization detects novel copy number alterations in gastric adenocarcinoma.
    Anticancer Res. 2014;34:6405-15.
    PubMed     Text format     Abstract available


    October 2014
  107. CHOU WC, Chen JS, Hung YS, Hsu JT, et al
    Plasma chromogranin A levels predict survival and tumor response in patients with advanced gastroenteropancreatic neuroendocrine tumors.
    Anticancer Res. 2014;34:5661-9.
    PubMed     Text format     Abstract available


    September 2014
  108. NAMIKAWA T, Munekage E, Fukudome I, Maeda H, et al
    Clinicopathological characteristics and therapeutic outcomes of synchronous gastric adenocarcinoma and gastric lymphoma.
    Anticancer Res. 2014;34:5067-74.
    PubMed     Text format     Abstract available


    August 2014
  109. MIYAMOTO H, Kunisaki C, Otsuka Y, Takahashi M, et al
    Macroscopic type is a prognostic factor for recurrence-free survival after resection of gastric GIST.
    Anticancer Res. 2014;34:4267-73.
    PubMed     Text format     Abstract available


  110. BATSAIKHAN BE, Yoshikawa K, Kurita N, Iwata T, et al
    Expression of Stathmin1 in gastric adenocarcinoma.
    Anticancer Res. 2014;34:4217-21.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: